FDA clears ACCU-CHEK Inform II
16 October 2012 | By Roche
Hospital point-of-care system for blood glucose testing with improved accuracy and wireless data transfer Next-generation system...
List view / Grid view
16 October 2012 | By Roche
Hospital point-of-care system for blood glucose testing with improved accuracy and wireless data transfer Next-generation system...
1 October 2012 | By Roche
Updated survival results from the Phase III EMILIA study...
1 October 2012 | By Roche
Final results from the Phase III HERA trial...
24 September 2012 | By
Data on 13 of its investigational and approved products will be presented at ESMO 2012...
24 September 2012 | By Roche
For the treatment of women with recurrent, platinum-sensitive ovarian cancer...
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
13 September 2012 | By Roche
Roche has been recognised as the most sustainable healthcare company...
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
28 August 2012 | By Roche
Daniel O’Day appointed new Head of Roche Pharma– Roland Diggelmann will assume the position Head of Roche Diagnostics...
27 August 2012 | By Roche
Pivotal study met co-primary efficacy endpoint of overall survival...
13 August 2012 | By Roche
First major treatment advance in more than 25 years for sight-threatening condition...
10 August 2012 | By Roche
Phase III study met its co-primary endpoint...
27 July 2012 | By Roche
Data will be submitted to health authorities globally...
26 July 2012 | By Roche
Fully automated assay for widely available platforms offers labs efficient solution to help assess patient vitamin D levels...
23 July 2012 | By Roche
Almost four times as many patients achieve remission with RoActemra (tocilizumab) compared to Humira (adalimumab)...